These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 15739288)

  • 1. Ethical and legal dimensions of benzodiazepine prescription: a commentary.
    Bursztajn HJ; Brodsky A
    Psychiatr Ann; 1998 Mar; 28(3):121-7. PubMed ID: 15739288
    [No Abstract]   [Full Text] [Related]  

  • 2. Prescribing benzodiazepines for patients with substance use disorders.
    Lieberman DZ
    J Clin Psychiatry; 2004 Nov; 65(11):1577; author reply 1577-8. PubMed ID: 15554778
    [No Abstract]   [Full Text] [Related]  

  • 3. Physicians' liability for off-label prescriptions.
    Riley JB; Basilius PA
    Nephrol News Issues; 2007 Jun; 21(7):43-4, 46-7. PubMed ID: 17623984
    [No Abstract]   [Full Text] [Related]  

  • 4. Taking back your turf: understanding the role of law in medical decision making in opioid management (Part I--overview).
    Bolen J
    J Opioid Manag; 2005; 1(3):125-30. PubMed ID: 17315415
    [No Abstract]   [Full Text] [Related]  

  • 5. THE OPI0ID ABUSE EPIDEMIC. PROTECT YOURSELF FROM LIABILITY.
    Brunken JD
    Med Econ; 2015 Aug; 92(16):57. PubMed ID: 26540790
    [No Abstract]   [Full Text] [Related]  

  • 6. Are there guidelines for the responsible prescription of benzodiazepines?
    el-Guebaly N; Sareen J; Stein MB
    Can J Psychiatry; 2010 Nov; 55(11):709-14. PubMed ID: 21070698
    [No Abstract]   [Full Text] [Related]  

  • 7. Off-label marketing stirs a legal hornet's nest.
    Guglielmo WJ
    Med Econ; 2006 Oct; 83(19):47-9. PubMed ID: 17066854
    [No Abstract]   [Full Text] [Related]  

  • 8. Taking back your turf: understanding the role of law in medical decision making in opioid management (Part II--putting legal/regulatory materials to work for you).
    Bolen J
    J Opioid Manag; 2005; 1(4):185-92. PubMed ID: 17315544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multiple schedule II prescriptions: the final rule.
    Brushwood DB
    J Pain Palliat Care Pharmacother; 2008; 22(2):139-43. PubMed ID: 19042838
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethical and Legal Aspects of Prescription Stimulant Use by Medical Students.
    Patel N; Sade RM
    J S C Med Assoc; 2015 Jan; 110(4):127-33. PubMed ID: 27141693
    [No Abstract]   [Full Text] [Related]  

  • 11. Controlled Substance Prescribing Patterns--Prescription Behavior Surveillance System, Eight States, 2013.
    Paulozzi LJ; Strickler GK; Kreiner PW; Koris CM;
    MMWR Surveill Summ; 2015 Oct; 64(9):1-14. PubMed ID: 26469747
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A pediatrician's view. Dangerous alliances.
    Altemeier WA
    Pediatr Ann; 1997 Mar; 26(3):155-6, 159. PubMed ID: 9084051
    [No Abstract]   [Full Text] [Related]  

  • 13. Conflicts of interest, continued.
    JAMA; 1990 Mar; 263(9):1199-200. PubMed ID: 2304232
    [No Abstract]   [Full Text] [Related]  

  • 14. [Is the legally responsible party indeed responsible? An ethical-legal question on the term].
    Fontana-Rosa JC; Oliveira RA
    Rev Assoc Med Bras (1992); 2008; 54(3):279-82. PubMed ID: 18604410
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence-based medicine on trial.
    Fleming M
    JAMA; 2004 Apr; 291(14):1697-8; author reply 1698. PubMed ID: 15082691
    [No Abstract]   [Full Text] [Related]  

  • 16. Evidence-based medicine on trial.
    Morse LJ
    JAMA; 2004 Apr; 291(14):1697; author reply 1698. PubMed ID: 15082693
    [No Abstract]   [Full Text] [Related]  

  • 17. Evidence-based medicine on trial.
    Hall MA; Green MD; Hartz A
    JAMA; 2004 Apr; 291(14):1697; author reply 1698. PubMed ID: 15082690
    [No Abstract]   [Full Text] [Related]  

  • 18. A piece of my mind. Winners and losers.
    Merenstein D
    JAMA; 2004 Jan; 291(1):15-6. PubMed ID: 14709561
    [No Abstract]   [Full Text] [Related]  

  • 19. A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population.
    Ross-Degnan D; Simoni-Wastila L; Brown JS; Gao X; Mah C; Cosler LE; Fanning T; Gallagher P; Salzman C; Shader RI; Inui TS; Soumerai SB
    Int J Psychiatry Med; 2004; 34(2):103-23. PubMed ID: 15387395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health Law and Medical Practice.
    Chesnokova AE
    AMA J Ethics; 2016 Mar; 18(3):197-200. PubMed ID: 27459738
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.